Dr. Jennifer Carney
Claim this profileKaiser Permanente Moanalua Medical Center
Studies Breast Cancer
Studies Follicular Lymphoma
8 reported clinical trials
18 drugs studied
Area of expertise
1Breast Cancer
Stage IV
Stage III
ER positive
2Follicular Lymphoma
EZH2 positive
CNG positive
CNG negative
Affiliated Hospitals
Clinical Trials Jennifer Carney is currently running
Tazemetostat + Lenalidomide + Rituximab
for Follicular Lymphoma
The participants of this study would have relapsed/refractory follicular lymphoma. Follicular lymphoma is a type of blood cancer. It is referred to as 'relapsed' when the disease has come back after a period of improvement after that follows a treatment regimen and 'refractory' when treatment no longer works. Stage 1 of this trial will study the safety and the level that adverse effects of each of the study drug combinations can be tolerated (known as tolerability). It is also designed to establish a recommended study drug dosage for stage 2 and 3. Stage 1 of the study is completed. Stages 2 and 3 will evaluate and compare how long participants live without their disease getting worse when receiving the study drug in combination with other drug treatment versus the placebo (dummy drug) in combination with other drug treatment.
Recruiting1 award Phase 34 criteria
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
More about Jennifer Carney
Clinical Trial Related6 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Jennifer Carney has experience with
- Placebo
- Tucatinib
- Abemaciclib
- Imlunestrant
- Exemestane
- T-DM1
Breakdown of trials Jennifer Carney has run
Breast Cancer
Follicular Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jennifer Carney specialize in?
Jennifer Carney focuses on Breast Cancer and Follicular Lymphoma. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are Stage III.
Is Jennifer Carney currently recruiting for clinical trials?
Yes, Jennifer Carney is currently recruiting for 2 clinical trials in Honolulu Hawaii. If you're interested in participating, you should apply.
Are there any treatments that Jennifer Carney has studied deeply?
Yes, Jennifer Carney has studied treatments such as Placebo, Tucatinib, Abemaciclib.
What is the best way to schedule an appointment with Jennifer Carney?
Apply for one of the trials that Jennifer Carney is conducting.
What is the office address of Jennifer Carney?
The office of Jennifer Carney is located at: Kaiser Permanente Moanalua Medical Center, Honolulu, Hawaii 96819 United States. This is the address for their practice at the Kaiser Permanente Moanalua Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.